BiotechTube

Placebo + Pregabalin + Pregabalin + Pregabalin

Phase 3Completed
0 watching 0 views this week📈 Rising
76
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Neuralgia, Postherpetic

Conditions

Neuralgia, Postherpetic

Trial Timeline

Sep 1, 2006 → Nov 1, 2007

NCT ID
NCT00394901

About Placebo + Pregabalin + Pregabalin + Pregabalin

Placebo + Pregabalin + Pregabalin + Pregabalin is a phase 3 stage product being developed by Pfizer for Neuralgia, Postherpetic. The current trial status is completed. This product is registered under clinical trial identifier NCT00394901. Target conditions include Neuralgia, Postherpetic.

Hype Score Breakdown

Clinical
27
Activity
18
Company
9
Novelty
9
Community
10

Clinical Trials (1)

NCT IDPhaseStatus
NCT00394901Phase 3Completed

Competing Products

20 competing products in Neuralgia, Postherpetic

See all competitors
ProductCompanyStageHype Score
Placebo + DS-5565Daiichi SankyoPre-clinical
23
QUTENZAAstellas PharmaApproved
85
ASP8477 + PlaceboAstellas PharmaPhase 2
52
E2007 (perampanel) + PlaceboEisaiPhase 2
52
E2007EisaiPhase 2/3
65
KHK6188 + PlaceboKyowa KirinPhase 2
52
ONO-1110 + PlaceboOno PharmaceuticalPhase 2
52
GalcanezumabEli LillyApproved
85
Placebo + Pregabalin SR tablet 165mg/day + Pregabalin SR tablet 330mg/day + Pregabalin SR tablet 660mg/dayJiangsu Hengrui MedicinePhase 3
77
ABT-894 + ABT-894 + ABT-894 + placebo + DuloxetineAbbViePhase 2
52
MK-8291 + PlaceboMerckPhase 1
33
Etoricoxib + PlaceboMerckApproved
85
Cetuximab + PlaceboMerckPhase 2
52
ADL5747 + Placebo + PregabalinMerckPhase 2
52
MK0759MerckPhase 2
52
MK0686MerckPhase 2
52
Comparator: pregabalin + Comparator: Placebo (unspecified)MerckPhase 1
33
EMA401 + PlaceboNovartisPhase 2
52
pregabalinPfizerApproved
84
Lyrica (pregabalin) + PlaceboPfizerApproved
84

Other Products from Pfizer

MeropenemApproved
84
celecoxibApproved
84
13vPnCApproved
84
EtanerceptApproved
84
AtorvastatinApproved
84